17-hydroxyprogesterone caproate for women with history of preterm birth in a prior pregnancy and twins in the current pregnancy

被引:6
|
作者
Combs, C. Andrew [1 ]
Garite, Thomas J. [1 ]
Maurel, Kimberly
Cebrik, Deborah [2 ]
机构
[1] Ctr Res Educ & Qual, Obstetrix Med Grp, Sunrise, FL USA
[2] Axistat Inc, Biostat, San Francisco, CA USA
关键词
D O I
10.1016/j.ajog.2011.10.484
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
466
引用
收藏
页码:S213 / S213
页数:1
相关论文
共 50 条
  • [1] The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
    Ransom, Carla E.
    Chin, Jeanette R.
    Roeder, Hilary A.
    Sinclair, Tammy R.
    Heine, R. Phillips
    Murtha, Amy P.
    JOURNAL OF PREGNANCY, 2011, 2011 : 286483
  • [2] Adherence rates and outcomes for 17-hydroxyprogesterone caproate use in women with a previous history of preterm birth
    Edwards, Alexandra M.
    Lowry, Sarah A.
    Mikovich, Sam
    Forinash, Alicia B.
    Babbar, Shilpa
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2020, 2 (03)
  • [3] Use of 17-Hydroxyprogesterone Caproate in Twin Gestations With a Prior Singleton Spontaneous Preterm Birth
    Ward, Andrew R.
    Greenberg, Victoria Rachel
    Valcarcel, Breanna
    Al-Kouatly, Huda Bachir
    Berghella, Vincenzo
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 221S - 221S
  • [4] Use of 17-α-hydroxyprogesterone-caproate did not predict pregnancy prolongation in women with prior spontaneous preterm birth
    Massa, Katherine
    Childress, Katherine S.
    Vricella, Laura K.
    Tomlinson, Tracy M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S573 - S574
  • [5] A randomized controlled trial of 17-hydroxyprogesterone caproate (17-DHPC) for the prevention of preterm birth in twins
    Caritis, Steve
    Rouse, Dwight
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) : S2 - S2
  • [6] Impact of Pregnancy History and 17-Hydroxyprogesterone Caproate on Cervical Cytokines and Matrix Metalloproteinases
    Caritis, Steve N.
    Hankins, Gary
    Hebert, Mary
    Haas, David M.
    Ahmed, Mahmoud
    Simhan, Hyagriv
    Haneline, Laura A.
    Harris, John
    Chang, Justine
    Famy, Alyssa Stephenson
    Yorio, Patrick
    Ren, Zhaoxia
    D'Alton, Mary E.
    Venkataramanan, Raman
    AMERICAN JOURNAL OF PERINATOLOGY, 2018, 35 (05) : 470 - 480
  • [7] Fetal Fibronectin versus Cervical Length as Predictors of Preterm Birth in Twin Pregnancy with or without 17-Hydroxyprogesterone Caproate
    Combs, C. Andrew
    Garite, Thomas J.
    Maurel, Kimberly
    Das, Anita
    AMERICAN JOURNAL OF PERINATOLOGY, 2014, 31 (12) : 1023 - 1029
  • [8] Recurrent preterm birth in women treated with 17 α-hydroxyprogesterone caproate: the contribution of risk factors in the penultimate pregnancy
    Coleman, Suzanne
    Wallace, Lisa
    Alexander, Jeffrey
    Istwan, Niki
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2012, 25 (07): : 1034 - 1038
  • [9] A randomized trial of 17-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV
    Price, Joan T.
    Vwalika, Bellington
    Freeman, Bethany L.
    Saha, Pooja T.
    Cole, Stephen R.
    Mbewe, Felistas
    Phiri, Winifreda M.
    Peterson, Marc
    Muyangwa, Dorothy
    Sindano, Ntazana
    Mwape, Humphrey
    Smithmyer, Megan E.
    Kasaro, Margaret P.
    Mofenson, Lynne M.
    Rouse, Dwight J.
    Goldenberg, Robert L.
    Chomba, Elwyn
    Stringer, Jeffrey
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S6 - S7
  • [10] Factors Associated with Utilization of 17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth
    DeNoble, Anna E.
    Wynn, Clara E.
    Weaver, Kristin E.
    Wheeler, Sarahn M.
    Swamy, Geeta K.
    AMERICAN JOURNAL OF PERINATOLOGY, 2020, 37 (03) : 264 - 270